✦ LIBER ✦

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study

✍ Scribed by Raymond S. Yeung; James L. Weese; John P. Hoffman; Lawrence J. Solin; Anthony R. Paul; Paul F. Engstrom; Samuel Litwin; Michael J. Kowalyshyn; Burton L. Eisenberg

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 1023 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931001)72:7<2124::aid-cncr2820720711>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of gemcitabine and doce

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

✍ David P. Ryan; Matthew H. Kulke; Charles S. Fuchs; Michael L. Grossbard; Steven 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Phase II evaluation of mitoxantrone in a

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

✍ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v

Post-therapy pathologic stage and surviv

Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation

✍ Jeannelyn S. Estrella; Asif Rashid; Jason B. Fleming; Matthew H. Katz; Jeffrey E 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

A phase II study of neoadjuvant biochemo

A phase II study of neoadjuvant biochemotherapy for stage III melanoma

✍ Peter Gibbs; Clay Anderson; Nathan Pearlman; Stacy LaClaire; Maude Becker; Krist 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Phase II study of amonafide in advanced

Phase II study of amonafide in advanced pancreatic adenocarcinoma

✍ Kaye Linke; Richard Pazdur; James L. Abbruzzese; Jaffer A. Ajani; Rodger Winn; J 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 262 KB

To determine the efficacy of amonafide in patients with advanced, measurable pancreatic adenocarcinoma, 15 patients previously untreated with chemotherapy were entered on a phase II trial. The starting dose was 400 mg/m 2 administered daily over 1 hr for 5 consecutive days repeated every 3 weeks. Be